Breaking News Instant updates and real-time market news.

MDT

Medtronic

$92.24

-0.03 (-0.03%)

07:19
02/20/19
02/20
07:19
02/20/19
07:19

Medtronic announces U.S. commercial launch of DBS

Medtronic announced both the U.S. launch of Deep Brain Stimulation, or DBS, for medically-refractory epilepsy and the first commercially implanted patient at Emory University in Atlanta, Georgia. According to the Epilepsy Foundation, as many as 3.4M Americans have epilepsy, with one-third estimated to be drug resistant. DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus, or ANT, which is part of a network involved in seizures. Recently, the FDA granted pre-market approval for Medtronic DBS Therapy for Epilepsy as adjunctive treatment for reducing the frequency of partial-onset seizures in individuals 18 years of age or older who are refractory, or drug-resistant, to three or more antiepileptic medications. The approval was based on results from the SANTE trial, wherein patients had a median seizure frequency reduction of 75 percent at seven years post-implant.

  • 25

    Feb

  • 06

    Mar

  • 18

    May

MDT Medtronic
$92.24

-0.03 (-0.03%)

01/08/19
LEHM
01/08/19
NO CHANGE
Target $104
LEHM
Overweight
Medtronic price target lowered to $104 from $113 at Barclays
Barclays analyst Kristen Stewart lowered her price target for Medtronic to $104 saying management yesterday made some cautious commentary on the near-term sales outlook and recent tax regulation proposals. It seems that Medtronic "is a bit two steps forward and now one step back," Stewart tells investors in a research note. The analyst, who is not surprised by the 6.5% selloff yesterday, keeps an Overweight rating on the shares, citing valuation and Medtronic's longer term growth prospects with its pipeline.
01/15/19
BTIG
01/15/19
UPGRADE
Target $100
BTIG
Buy
Medtronic upgraded to Buy from Neutral at BTIG
BTIG analyst Sean Lavin upgraded Medtronic to Buy with a price target of $100, saying the recent sell-off in the stock presents an attractive entry point on a "compelling relative valuation". The analyst notes that the company's recent beats have been impressive, but he had been concerned over the difficult expected comps for the second half of the year. Lavin adds that with the "new CVG concerns and cautionary language around tax proposals", Medtronic stock has become especially attractive, especially given his expectation of "results in upcoming quarters, paclitaxel concerns easing, tax changes not materializing, and enthusiasm around low-risk expansion".
02/04/19
PIPR
02/04/19
NO CHANGE
PIPR
Overweight
Piper says UnitedHealth updated policy won't have real impact on Tandem revenue
Piper Jaffray analyst JP McKim said some will interpret UnitedHealth's (UNH) recently updated insulin pump policy, which expands Medtronic's (MDT) preferential agreement to patients age 7 and older, to mean that Tandem Diabetes (TNDM) "is farther away from getting back into good graces" with the insurer. However, while he understands that logic, McKim said he cannot know for sure either way and he thinks it won't have any real impact on Tandem's revenues. McKim, who keeps an Overweight rating on Tandem Diabetes shares, added that "patients and physicians hate this agreement as everyone wants open options for patients."
02/19/19
PIPR
02/19/19
NO CHANGE
PIPR
Overweight
Piper says Medtronic business momentum should keep driving shares higher
Following Medtronic's Q3 report of a top and bottom-line beat, Piper Jaffray analyst Matt O'Brien noted that the company's results have beat expectations for 5 quarters in a row, adding that he is encouraged by all of the pipeline products that are ahead. O'Brien, who believes the momentum in the business will continue driving the stock higher, reiterated an Overweight rating on Medtronic shares.

TODAY'S FREE FLY STORIES

EHC

Encompass Health

$64.68

0.905 (1.42%)

17:10
09/16/19
09/16
17:10
09/16/19
17:10
Initiation
Encompass Health initiated  »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 19

    Sep

AMCR

Amcor

$9.68

-0.53 (-5.19%)

17:10
09/16/19
09/16
17:10
09/16/19
17:10
Hot Stocks
Amcor's Stephan sells nearly 70,000 ordinary shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$378.87

-1 (-0.26%)

17:10
09/16/19
09/16
17:10
09/16/19
17:10
Periodicals
Panel set to criticize FAA's approval process for Boeing 737 MAX jets, WSJ says »

Andy Pasztor and Andrew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

VFF

Village Farms

$10.89

-0.81 (-6.92%)

17:05
09/16/19
09/16
17:05
09/16/19
17:05
Hot Stocks
Village Farms joint venture begins shipping to Ontario, launches this month »

Village Farms announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CKH

Seacor

$49.74

-0.46 (-0.92%)

17:04
09/16/19
09/16
17:04
09/16/19
17:04
Hot Stocks
Seacor announces major rebranding of subsidiaries »

Seacor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STXS

Stereotaxis

$4.22

0.58 (15.93%)

17:02
09/16/19
09/16
17:02
09/16/19
17:02
Hot Stocks
Stereotaxis appoints Kimberly Peery CFO »

Stereotaxis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$378.87

-1 (-0.26%)

17:01
09/16/19
09/16
17:01
09/16/19
17:01
Periodicals
Breaking Periodicals news story on Boeing »

Panel set to find fault…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

SEM

Select Medical

$16.97

0.01 (0.06%)

16:58
09/16/19
09/16
16:58
09/16/19
16:58
Initiation
Select Medical initiated  »

Select Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

FB

Facebook

$186.24

-0.73 (-0.39%)

, AMZN

Amazon.com

$1,808.21

-29.28 (-1.59%)

16:57
09/16/19
09/16
16:57
09/16/19
16:57
Periodicals
U.S antitrust regulators bicker over big tech probe, WSJ reports »

John McKinnon and Brent…

FB

Facebook

$186.24

-0.73 (-0.39%)

AMZN

Amazon.com

$1,808.21

-29.28 (-1.59%)

GOOG

Alphabet

$1,231.36

-8.24 (-0.66%)

NFLX

Netflix

$294.21

0.21 (0.07%)

AAPL

Apple

$219.88

1.17 (0.53%)

MSFT

Microsoft

$136.39

-0.82 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 16

    Oct

  • 27

    Oct

KTOV

Kitov Pharmaceuticals

$0.81

-0.003 (-0.37%)

16:56
09/16/19
09/16
16:56
09/16/19
16:56
Syndicate
Breaking Syndicate news story on Kitov Pharmaceuticals »

Kitov Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPRA

Opera

$12.95

-0.14 (-1.07%)

16:55
09/16/19
09/16
16:55
09/16/19
16:55
Syndicate
Opera files to sell 7M American Depositary Shares »

Citigroup Global Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ZAYO

Zayo Group

$33.83

0.01 (0.03%)

16:51
09/16/19
09/16
16:51
09/16/19
16:51
Hot Stocks
Zayo Group COO sells 14,993 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

LHCG

LHC Group

$118.42

0.8 (0.68%)

16:50
09/16/19
09/16
16:50
09/16/19
16:50
Initiation
LHC Group initiated  »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 13

    Nov

AMED

Amedisys

$130.73

-2.13 (-1.60%)

16:47
09/16/19
09/16
16:47
09/16/19
16:47
Initiation
Amedisys initiated  »

Amedisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

HLM

Hillman Companies

$0.00

(0.00%)

16:46
09/16/19
09/16
16:46
09/16/19
16:46
Hot Stocks
Hillman CEO Greg Gluchowski leaving company due to family medical issues »

The Hillman Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

16:45
09/16/19
09/16
16:45
09/16/19
16:45
Hot Stocks
Breaking Hot Stocks news story on Aclaris Therapeutics »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$18.50

8.45 (84.08%)

16:40
09/16/19
09/16
16:40
09/16/19
16:40
Upgrade
Alder Biopharmaceuticals rating change  »

Alder upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 21

    Feb

XON

Intrexon

$6.86

0.44 (6.85%)

16:39
09/16/19
09/16
16:39
09/16/19
16:39
Hot Stocks
Intrexon falls after dismissing accountant, notes 'going concern' language »

On September 10, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$337.93

-0.77 (-0.23%)

16:38
09/16/19
09/16
16:38
09/16/19
16:38
Syndicate
Shopify files to sell 1.9M Class A subordinate voting shares »

The offering will be led…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

KTOV

Kitov Pharmaceuticals

$0.81

-0.003 (-0.37%)

16:37
09/16/19
09/16
16:37
09/16/19
16:37
Syndicate
Kitov Pharmaceuticals files to sell 2.81M ADSs for holders »

These American Depositary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRQ

Dril-Quip

$55.40

3.36 (6.46%)

16:37
09/16/19
09/16
16:37
09/16/19
16:37
Hot Stocks
Dril-Quip discloses termination of Ca Rong Do project, maintains guidance »

Dril-Quip announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WOW

WideOpenWest

$6.24

0.325 (5.49%)

16:36
09/16/19
09/16
16:36
09/16/19
16:36
Hot Stocks
WOW! names Bill Case CIO, announces departure of CTO Bell »

WOW! Internet, Cable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$44.67

0.75 (1.71%)

16:35
09/16/19
09/16
16:35
09/16/19
16:35
Hot Stocks
Acceleron announces ACE-083 trial does not meet secondary endpoints »

Acceleron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

DMTK

DermTech

$5.80

-0.18 (-3.01%)

16:34
09/16/19
09/16
16:34
09/16/19
16:34
Hot Stocks
DermTech names Kevin Sun CFO »

DermTech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$86.22

0.38 (0.44%)

16:32
09/16/19
09/16
16:32
09/16/19
16:32
Hot Stocks
Leidos awarded $428M ISR support services contract from U.S. Army »

Leidos has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.